Peter J. Pitts

发表

Perspectiv e Turning Point Or Tipping Point: New FDA Draft Guidances And The Future Of DTC Advertising How to harness the power of direct-to-consumer advertising to create better-informed consumers and better potential customers.

Peter J. Pitts, 2004 .

21st Century Pharmacovigilance: Intuition, Science, and the Role of Artificial Intelligence

Peter J. Pitts, 2017 .

Associate Editor's Commentary: Government Detailing

Peter J. Pitts, 2012 .

Health Literacy: The Common Denominator of Healthcare Progress

Peter J. Pitts, E. Freeman, 2021, The Patient - Patient-Centered Outcomes Research.

Government Detailing

Peter J. Pitts, 2012 .

A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia

Peter J. Pitts, H. Aljadhey, S. Perez-Gutthann, 2015, Saudi medical journal.

Associate Editor’s Commentary

Peter J. Pitts, 2012 .

Implications of CRISPR-Based Germline Engineering for Cancer Survivors

Peter J. Pitts, Gregory Katz, 2017, Therapeutic innovation & regulatory science.

21st century pharmacovigilance: efforts, roles, and responsibilities.

Peter J. Pitts, R. Conti, Y. Moride, 2016, The Lancet. Oncology.

openFDA: An Open Question.

Peter J. Pitts, 2015, Therapeutic Innovation and Regulatory Science.

Twenty-First Century Global ADR Management: A Need for Clarification, Redesign, and Coordinated Action

Peter J. Pitts, H. Le Louët, 2022, Therapeutic innovation & regulatory science.

The need for distinct nomenclature for originator and biosimilar products

Peter J. Pitts, R. Campbell, Michael Sarshad, 2018, GaBI Journal.

Advancing pharmaceuticals and patient safety in Saudi Arabia: A 2030 vision initiative

Peter J. Pitts, Tariq M. Alhawassi, Hatem A. Abuelizz, 2017, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

FDA and the critical path to twenty-first-century medicine.

Peter J. Pitts, 2008, The Journal of medicine and philosophy.

Our Most Powerful Weapon to Fight COVID-19: Patient Involvement

Peter J. Pitts, 2020, The Patient - Patient-Centered Outcomes Research.

The Pogo-ization of Post-Pandemic Vaccine Policy

Peter J. Pitts, 2023, Patient.

Trust and science: Public health's home field advantage in addressing vaccine hesitancy and improving immunization rates.

Peter J. Pitts, G. Poland, 2023, Vaccine.

The Case for Methodological Pluralism in Medical Science

Peter J. Pitts, T. Bock, S. Edwards, 2020, The American Journal of Bioethics.

Implications of CRISPR-Based Germline Engineering for Cancer Survivors

Peter J. Pitts, Gregory Katz, 2017, Therapeutic innovation & regulatory science.

Impact of Real-World Data on Market Authorization, Reimbursement Decision & Price Negotiation

Peter J. Pitts, Gregory Katz, Gabriela Martins Caetano, 2020, Therapeutic Innovation & Regulatory Science.